account(MENAFN - Asia Pulse) AXIRON NDA currently under review by U.S. FDA for the treatment of testosterone deficiency in men Eli Lilly and Company (NYSE:...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Australia- Lilly To Acquire Global License To Axiron Testosterone...
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account